Protara Therapeutics Completes 24-Patient Enrollment In Phase 2b Trial Of IV Choline Chloride For Intestinal Failure; Interim Data Expected In Q4

Loading news article.

Protara Therapeutics Completes 24-Patient Enrollment In Phase 2b Trial Of IV Choline Chloride For Intestinal Failure; Interim Data Expected In Q4 | WAPE

Protara Therapeutics Completes 24-Patient Enrollment In Phase 2b Trial Of IV Choline Chloride For Intestinal Failure; Interim Data Expected In Q4

Article summary

Related companies

Analyzed by WAPE AI.

Comments —